US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Evome Medical Technologies Inc (EM) (LNDZF) 銘柄情報

Evome Medical Technologies Inc (EM) (LNDZF)

0.000001

0.00

( 0.00% )

更新日時： 09:00:00

Evome Medical Technologies Inc (EM) (LNDZF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.000001

( - )

買値

0.00

売値

0.00

出来高

-

0.00 日の範囲 0.00

0.000001 52 週間の範囲 0.0001

時価総額

前日終値

0.000001

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 0

発行済株式数

83,000,329

配当利回り

PER

-0.02

1 株当たり利益 (EPS)

-0.27

歳入

48.34M

純利益

-23.53M

Evome Medical Technologies Inc. designs, develops, produces, and sells medical devices in the United States. The company was formerly known as Salona Global Medical Device Corporation and changed its name to Evome Medical Technologies Inc. in January 2024. The company is based in Shirley, New York. Evome Medical Technologies Inc. designs, develops, produces, and sells medical devices in the United States. The company was formerly known as Salona Global Medical Device Corporation and changed its name to Evome Medical Technologies Inc. in January 2024. The company is based in Shirley, New York.

セクター

Healthcare

業界

Medical Equipment & Supplies

本社

Shirley, United States

設立

-

Evome Medical Technologies Inc (EM) is listed in the Healthcare sector of the その他OTC with ticker LNDZF. The last closing price for Evome Medical Technologies (EM) was US$0. Over the last year, Evome Medical Technologies (EM) shares have traded in a share price range of US$ 0.000001 to US$ 0.0001.

Evome Medical Technologies (EM) currently has 83,000,329 shares in issue. The market capitalisation of Evome Medical Technologies (EM) is US$83 . Evome Medical Technologies (EM) has a price to earnings ratio (PE ratio) of -0.02.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	1.0E-6	1.0E-6	1.0E-6	2500	1.0E-6	CS
26	0	0	1.0E-6	1.0E-6	1.0E-6	1875	1.0E-6	CS
52	0	0	1.0E-6	0.0001	1.0E-6	43142	2.34E-6	CS
156	-0.201499	-99.9995037221	0.2015	0.315	1.0E-6	22622	0.05931398	CS
260	-0.819999	-99.9998780488	0.82	1.3	1.0E-6	21802	0.49916918	CS

LNDZF - Frequently Asked Questions (FAQ)

What is the current Evome Medical Technologies Inc (EM) share price?

The current share price of Evome Medical Technologies Inc (EM) is US$ 0.000001

How many Evome Medical Technologies Inc (EM) shares are in issue?

Evome Medical Technologies Inc (EM) has 83,000,329 shares in issue

What is the market cap of Evome Medical Technologies Inc (EM)?

The market capitalisation of Evome Medical Technologies Inc (EM) is USD 83

What is the 1 year trading range for Evome Medical Technologies Inc (EM) share price?

Evome Medical Technologies Inc (EM) has traded in the range of US$ 0.000001 to US$ 0.0001 during the past year

What is the PE ratio of Evome Medical Technologies Inc (EM)?

The price to earnings ratio of Evome Medical Technologies Inc (EM) is -0.02

What is the cash to sales ratio of Evome Medical Technologies Inc (EM)?

The cash to sales ratio of Evome Medical Technologies Inc (EM) is 0.01

What is the registered address of Evome Medical Technologies Inc (EM)?

The registered address for Evome Medical Technologies Inc (EM) is 49 Natcon Drive, Shirley, New York, 11967

Which industry sector does Evome Medical Technologies Inc (EM) operate in?

Evome Medical Technologies Inc (EM) operates in the Medical Equipment & Supplies sector

learningcurve2020

learningcurve2020 3分前

If patients are really what matters DCVAX either would have been placed in capable hands or scuttled many years ago. 🤷‍♀️. Based on that latest LL Brown piece it seems like it may have been scuttled back in 2019?

BottomBounce

BottomBounce 4分前

US bonds could struggle through 2026-2030 as it loses safe-haven status to Gold and Silver bullion at lowest prices in years

Helter Skelter

Helter Skelter 4分前

Got it! New 52 wk hi @ 10.98. 11 break imminent! 😁

bigballz

bigballz 4分前

How many shares should AIMN have outstanding ? And I agree that the market makers are the Real Crooks?

BottomBounce

BottomBounce 4分前

US bonds could struggle through 2026-2030 as it loses safe-haven status to Gold and Silver bullion at lowest prices in years

US Market News

US Market News 4分前

Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock SplitJune 26, 2026 9:42 AM
PR Newswire (US) Eleven sites open for patient enrollment i

Trooperstocks

Trooperstocks 4分前

$ILLR CEO Wing Fai Ng: "We now have four clear engines of value working for shareholders"

• Social & Creator platform (327M+ Triller accounts)
• Sports & Live Events (Eight Sports Capital / BKFC)
• Asian Financial Services (AGBA)
• Strategic Treasury (new SpaceX

glenn1919

glenn1919 4分前

WKSP............................https://stockcharts.com/sc3/ui/?s=WKSP&p=w&b=5&g=0&id=p86431144783

US Market News

US Market News 5分前

Insurance Advisors Advance Global AI TransformationsJune 26, 2026 10:00 AM
Business Wire Insurers seek partners to carry out AI adoption and operating model redesign, achieving measurable business outcomes, ISG Provider Lens® report says Insu

Covid19freak

Covid19freak 5分前

CALC 0.65 could breakout back over 1dollar , a very cheap stock with phase 3 ready drug .

Bngo

Are you saying that Amneal might acquire Elite for: generic Eliquis, generic Oxycodone, generic anticonvulsant, Elite’s pipeline with multiple needle movers drugs in BE studies mode, and potential more sales in Israel with generic Adderal ER and generic Vyvanse?I think they might acquire Elite to he

OldAIMGuy

OldAIMGuy 5分前

JETS has been a good stock to trade around my core position. Here's what the last three years have looked like:

https://investorshub.advfn.com/uimage/uploads/2026/6/26/rulseJETS_STKCHRTS.jpg

I've been trading roughly 10% of the position at each inflection point. Here's

Baxy

$BIEI at 1.6m market cap this is where you can make 10x or 100x

surfkast

surfkast 6分前

I rarely play down here but I went in.

TexasMarvL

TexasMarvL 6分前

Hopefully July has a couple of News Releases as expected. Glamorgan and Reefton projects both expect permit approvals in July.

https://youtu.be/rUwNxEDxAVI?is=npPqltQpbQ0QDMqq

BottomBounce

BottomBounce 6分前

PRECIOUS METALS GOLD & SILVER ARE ON FIRE

Monksdream

Monksdream 6分前

IVF, there it goes

BottomBounce

BottomBounce 6分前

PRECIOUS METALS GOLD & SILVER ARE ON FIRE

Trooperstocks

Trooperstocks 6分前

$ILLR CEO Wing Fai Ng: "We now have four clear engines of value working for shareholders"

• Social & Creator platform (327M+ Triller accounts)
• Sports & Live Events (Eight Sports Capital / BKFC)
• Asian Financial Services (AGBA)
• Strategic Treasury (new SpaceX

Guido2

Just having a bill that includes the phrase, "end of conservatorship" isn't necessarily a good thing. Increasing CRTs is going to reduce their future income. So too, restrictions on their MBS portfolios. These are bipartisan crooks like CorkerWarner a few years ago, beholden to TBTF banks.

Porch Honkey

Porch Honkey 6分前

$AEFI,
https://x.com/tharris789/status/2070292293001855294?s=20

rosemountbomber

rosemountbomber 6分前

Doesn't seem to be trading like a bio stock with FDA approval a day or two away. Can only hope that:

a) we do get approval, and
b) that since we did not have a terrific runup in advance, that there is no "sell the news" event afterwards.

glenn1919

glenn1919 6分前

CNEY..........................https://stockcharts.com/sc3/ui/?s=CNEY&p=W&b=5&g=0&id=p86431144783

Renee

NBDR: ORDERED that the petition filed by No Borders, Inc. and Joseph Snyder requesting
termination of the Commission’s April 3, 2020, order suspending trading in No Borders, Inc.’s
securities for a period of 10 days be denied.

By the Commission

https://www

Helter Skelter

Helter Skelter 7分前

$BB looking for a 11 break and/or new 52 wk hi @ 10.94!

Evome Medical Technologies (EM)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。